The Sub-fund aims to outperform (after deduction of costs) the MSCI ACWI Index, as stated in sterling, by at least 2.5% per annum over rolling five-year periods. The Sub-fund will invest at least 90% in shares of companies that have the potential to deliver substantial improvements to human health, lengthen lifespans and reduce healthcare costs. The companies that the Sub-fund invests in will bring innovation to human health through increasing understanding and detection of disease, and by improving treatments, devices and operational efficiencies. The Sub-fund will be actively managed and will invest in companies in any country and of any size.
What is Baillie Gifford Health Innovt B GBP Acc stock price today?▼
The current price of GB00BMVLY038.LSE is £0.59 GBP — it has increased by +0.34% in the past 24 hours. Watch Baillie Gifford Health Innovt B GBP Acc stock price performance more closely on the chart.
What is Baillie Gifford Health Innovt B GBP Acc stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on London Exchange exchange Baillie Gifford Health Innovt B GBP Acc stocks are traded under the ticker GB00BMVLY038.LSE.
In which sector is Baillie Gifford Health Innovt B GBP Acc located?▼
Baillie Gifford Health Innovt B GBP Acc operates in the Other sector.
When did Baillie Gifford Health Innovt B GBP Acc complete a stock split?▼
Baillie Gifford Health Innovt B GBP Acc has not had any recent stock splits.